Auxilium Pharmaceuticals, Inc.

Discussion in 'Men's Economics' started by Michael Scally MD, Apr 30, 2014.

  1. Michael Scally MD

    Michael Scally MD Doctor of Medicine

    Auxilium Pharmaceuticals, Inc. Lowers 2014 Financial Guidance
    Auxilium Pharmaceuticals, Inc. Lowers 2014 Financial Guidance - WSJ.com


    CHESTERBROOK, Pa., April 29, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that it is reducing its financial guidance for the full year 2014 due primarily to lower-than-expected revenues from Testim(R) testosterone gel.